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Abstract
The awareness is growing of health hazards and pharmaceutical benefits of micro-/
nano-aerosol particles which are mostly nonspherical and hygroscopic, and categorized
as “unconventional” vs. solid spheres. Accurate and realistic numerical models will
significantly contribute to answering public health questions. In this chapter, funda-
mentals and future trends of computational fluid-particle dynamics (CFPD) models for
lung aerosol dynamics are discussed, emphasizing the underlying physics to simulate
unconventional  inhaled  aerosols  such  as  fibers,  droplets,  and  vapors.  Standard
simulation procedures are presented, including reconstruction of the human respiratory
system, CFPD model formulation, finite-volume mesh generation, etc. Case studies for
fiber and droplet transport and deposition in lung are also provided. Furthermore,
challenges and future directions are discussed to develop next-generation models. The
ultimate goal is to establish a roadmap to link different numerical models, and to build
the framework of a new multiscale numerical model, which will extend exposure and
lung deposition predictions to health endpoints, e.g., tissue and delivered doses, by
calculating absorption and translocation into alveolar regions and systemic regions
using  discrete  element  method  (DEM),  lattice  Boltzmann  method  (LBM),  and/or
physiologically based pharmacokinetic (PBPK) models. It will enable simulations of
extremely  complex  airflow-vapor-particle-structure  dynamics  in  the  entire  human
respiratory system at detailed levels.
Keywords: computational fluid-particle dynamics (CFPD) model, lung aerosol dynam-
ics, unconventional inhaled aerosol, fiber, droplet, vapor, whole lung model, lattice
Boltzmann method (LBM), compartmental modeling, physiologically based pharmaco-
kinetic (PBPK) modeling
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1. Introduction
Inhalable aerosols consist of multiple nano-to-micro-scale solid or liquid particulate matters
(PMs) with dissolved or embedded compounds, as well as associated vapors. Instead of being
spheres with constant diameters, most of these airborne PMs are nonspherical in shape, with
everchanging sizes due to evaporation/condensation. Therefore, they are defined as “uncon-
ventional  aerosol  particles”.  Examples  include  fiber-like  carbon  nanotubes  (CNTs)  [1],
hygroscopic cigarette particles [2–4], and pulmonary drug powders [5].
Both active and passive human exposures to ultrafine airborne aerosols are growing. Contri-
buting factors include the increase in nanomaterial generation during product/device manu-
facturing, handling and use [6], consumptions of conventional and new tobacco products [2–
4], as well as nanoparticle pulmonary drug development [7, 8]. Of great concern are the toxic
health risks and therapeutic benefits induced by the inhalation. This is mainly because the
small sizes facilitate ultrafine PM transport into deeper lung airways, translocation to the
bloodstream crossing body membrane barriers, thus affecting organs and tissues in both
pulmonary routes and systemic regions. For example, the transmission of respiratory infec-
tious disease begins from the deposition of pathogens carried by airborne PM into the
respiratory tract [9]. Since infection initiation is usually region specific, local dosages (i.e., lung
deposited, tissue, and delivered doses) in pulmonary routes and systemic regions are essential
for precise risk assessments. Another example is the worker exposure to airborne nanomate-
rials in the workplace [6]. Furthermore, pulmonary targeted drug delivery is favorable for both
lung and systemic disease treatments, owing to the strong capability of the lung to absorb
pharmaceuticals. Using ultrafine unconventional particles as drug carriers has also been
promoted in medical device design, encapsulation, and drug delivery [7, 8, 10], because of their
extraordinary capabilities to penetrate into deeper lung airways by virtue of the nonspherical
shape or the hygroscopic growth characteristics. In this case, accurate local dosage information
is also essential for the evaluation of drug delivery efficacy to targeted sites.
In light of the above discussion, the primary goal of relevant researches is to provide high-
resolution data and enhance the fundamental understanding of the physical and chemical
mechanisms for the dynamics of unconventional inhaled aerosols in human respiratory
systems and systemic regions. Data of interests include: transport, deposition, dissolution,
absorption, distribution, and clearance of unconventional aerosols in lung airways and
systemic regions under various exposure conditions. These data will also help to answer the
key question: “What type of inhaled aerosols deposits where at what surface concentrations in subject-
specific human respiratory systems under distinct breathing conditions, and what delivered dose into
the site of interest in systemic regions?”
Experiments or clinical tests are not able to provide such high-resolution data on human
subjects, because of ethical reasons and lack of reliable measurements. Hence, developing and
applying an accurate and realistic computer simulation model is desired. Different types of
numerical models have been developed specifically to determine the fate of inhaled aerosols
in human bodies, as has been reviewed recently by Phalen and Raabe [11]. To simulate particle
trajectories, interactions, and lung deposition of unconventional inhaled aerosols, computa-
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tional fluid-particle dynamics (CFPD) models based on Euler-Lagrange and Euler-Euler
methods are the best options compared to other numerical models such as empirical and
semiempirical ones [11]. Specifically, accurate prediction of the fate of such aerosols requires
the model to be able to capture the effects of particle shape and size change on their trajectories
before deposition. Based on more underlying physics and less extrapolations and simplifica-
tions, CFPD models are able to describe the fundamental behaviors of fluids and particles with
high-resolution local data by solving conservation laws with constitutive equations [3, 4, 10].
Hence, these validated noninvasive, cost-effective, and accurate CFPD models will comple-
ment in vitro and in vivo studies on unconventional lung aerosol dynamics by simulating
fluid-particle flows that are difficult to be reproduced experimentally. They will be able to
deliver new perspectives of scientific knowledge and healthcare data for medical device
improvements for effective and targeted drug deliveries, novel lung therapeutics, noninvasive
disease diagnostic methodologies, and exposure health risk evaluations. Accordingly, CFPD
models are expected to contribute to the following aspects:
1. Understand fundamental, physical, and chemical mechanisms that influence transport
phenomena of different inhaled aerosol.
2. Virtualize corrective surgery leading to improved breathing patterns in abnormal airways.
3. Enhance evaluating capabilities of toxicologists on adverse health effects of inhaled
particulate matters.
4. Design and engineer novel carriers for pulmonary drug delivery.
5. Establish guidelines for limiting workplace exposure to new nanoparticles and micron
fibers, considering both short-term and long-term exposures.
This chapter is intended to serve as an overview of advanced CFPD models for unconventional
inhaled aerosols and a demonstration of how to build and apply CFPD models on lung aerosol
dynamics simulations. It also shows a roadmap to the next-generation multiscale lung
dosimetry models. Specifically, fundamental mathematics of advanced CFPD modeling
techniques is introduced in Section 2, focusing on predicting unconventional aerosol transport
and deposition in human upper airways, i.e., nonspherical fiber, hygroscopic droplet, vapor
mixture, etc. Basic steps of CFPD modeling are also discussed in this section. Section 3 presents
applications of different advanced CFPD models with parametric sensitivity analyses on
particle transport and deposition characteristics in airways. Challenges and future directions
are discussed in Section 4 on developing next-generation multiscale numerical models, which
will be able to simulate unconventional aerosol transport, deposition, and translocation from
the complete pulmonary routes into systemic regions. Structured literature reviews on the
above topics are also integrated in the following sections. Other reviews can be found in [12, 13].
2. CFPD models for unconventional lung aerosols transport
Computational fluid-particle dynamics (CFPD) incorporates computational fluid dynamics
(CFD) theories with multiphase flow modeling techniques for particle dynamics in fluid flows,
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i.e., Euler-Euler and Euler-Lagrange methods [12, 13]. As shown in Figure 1, basic steps to
proceed simulations of transport and deposition of inhaled aerosol in human respiratory
systems using CFPD models include [11–13]: (1) reconstruction of the human respiratory
system, (2) mesh generation and independence test, (3) formulation of governing equation
system, (4) numerical discretization and solution, (5) model validation and revision, and (6)
aerosol transport and deposition visualization and analyses with insights.
Figure 1. Basic steps to perform CFPD simulations for transport and deposition of aerosols in human respiratory sys-
tems.
The underlying assumptions of conventional CFPD models are that the aerosols are spherical,
noninteracting, and constant in particulate diameter [12]. These assumptions induce inaccur-
acies in local deposition predictions when modeling the dynamics of unconventional aerosol
particles, e.g., nonspherical particles and hygroscopic droplets. To accurately capture the
transport and deposition of particulate matters, more physical and chemical principles must
be considered, such as the rotational motion of nonspherical fibers, particle-particle collisions
and coagulations, hygroscopic behaviors of droplets, as well as droplet-vapor phase transition,
which strongly impact their trajectories and subsequent deposition patterns in human
respiratory systems. Thus, advanced CFPD models have been developed and applied to
modeling unconventional particle dynamics [2, 3, 10, 13]. In this section, procedures for CFPD
modeling are discussed, followed by introducing governing equation systems of two advanced
CFPD models for ellipsoidal fiber dynamics and multicomponent droplet-vapor aerosol
transport in human respiratory systems.
2.1. Reconstruction of representative human respiratory systems
Since geometric variations have strong impacts on the airflow patterns leading to different
particle trajectories, the geometric accuracy of human respiratory system is of great impor-
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tance. Therefore, as the flow domain for CFPD modeling, the human respiratory system
geometry must be precise in anatomy and physiology.
2.1.1. Anatomy of human respiratory systems
Human respiratory system consists of respiratory passages, lung lobes, and respiratory
muscles (see Figure 2). Respiration includes three separate but related functions: ventilation
(breathing), gas exchange (between air and blood in the lungs and between the blood and
tissues), and oxygen utilization (by the tissues in the energy-liberating reactions of cell
respiration). During the respiration process, airborne particulate matters are also inhaled and
may settle in different locations. The internal walls of the human respiratory system are covered
by mucus layers. As a filtering mechanism, mucus layers serve to trap and clear the PM carried
by the lung airflow.
Figure 2. Schematics of human respiratory system (reprinted from [12]).
The human respiratory system ventilation path contains mouth, nose, pharynx, glottis, larynx,
trachea, bronchi, bronchioles (including terminal bronchioles (generation 16 (G16)) and
respiratory bronchioles (generation 17–19 (G17–G19)), and alveoli [14]. The path can be divided
into two functional zones. The conducting zone includes all of the anatomical structures
through which air passes before reaching the respiratory zone, i.e., mouth to terminal bron-
chioles (see Figure 2). The respiratory zone is the region where gas exchange occurs, which
includes respiratory bronchioles and alveoli.
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Human respiratory system can also be divided into upper airway and lower airway. The upper
airway is all structures above the glottis; the lower airway is from the vocal cords to the lung.
The upper airway include oral cavity, pharynx, larynx, and upper part of the trachea. Specif-
ically, oral cavity can be considered as having the shape of a prolate spheroid that features
different radius of curvatures along the sagittal and coronal planes. The shape of the orophar-
ynx is more circular before the glottal region. In the lower airway, the lung consists of 23
generations, encompassing 223 airways plus millions of alveoli of different shapes. There are
about 300 million alveoli (0.25–0.5 mm in diameter) in the lung which provide a high surface
area, i.e., 60–80 m2 for diffusion of gases. Each alveolus is only one cell-layer thick, so that the
total “air-blood barrier” is only two cells across (an alveolar cell and a capillary endothelial
cell), which is approximately 2 μm.
Another way is to divide the human respiratory system into three parts [12]: the extrathoracic
region (i.e., nose, mouth, and throat), the tracheobronchial part (i.e., trachea and bronchial
tree), and the alveolar region (i.e., alveolar ducts and sacs).
2.1.2. Idealized human upper airway geometries
Idealized geometries are built up of simple geometric shapes but possess all the basic ana-
tomical features of real human respiratory systems. At the early age, due to the limitations of
computational power and imaging techniques handling subject-specific geometries, the use of
idealized representative upper airway geometries is indispensable to investigate airflow and
aerosol deposition patterns [15–19]. Idealized tracheobronchial geometries are usually created
following airway dimensions measured by either Weibel [20] or Horsfield et al. [21]. They also
follow different sets of measurements [22, 23]. Two popular idealized geometries are shown
in Figure 3(a) and (b) [3, 18]. Figure 3(a) contains oral cavity, pharynx, larynx, and a symmetric,
planar triple-bifurcation lung airway representing G0–G3 after Cheng et al. [22] and Weibel
[20]. Figure 3(b) presents another idealized geometry with oral airways, nasal airways, and
asymmetric triple bifurcation unit (TBU) representing G0 to G3 following Alberta-Finlay
model [22] and Horsfield et al. [21]. Newly developed idealized human upper airway geome-
tries emphasize more on matching average aerosol deposition data measured in different
airway replicas [24].
Although idealized geometries are still beneficial for extensive fundamental transport
mechanism studies and easier model validations with in-vitro measurements [2, 3, 10, 25],
subject-specific respiratory system geometries are necessary to be employed for individualized
risk assessment or disease treatment. The importance of airway geometry on micron-particle
deposition was investigated and confirmed [26].
2.1.3. Subject-specific human upper airway geometries
Currently, more CAD-like subject-specific human upper airway geometry files are generated
via DICOM file conversion using either specialized software or in-house codes. An example
is shown in Figure 4. The geometry is from a 20-mm opening mouth inlet, to the tracheobron-
chial airways up to G9, which has been generated based on CT images. The subject for this
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study is a 47-year-old healthy male volunteer, 174 cm of height and 78 kg of weight. GE's 64-
slice CT scanner was used to take images of 500 × 500 mm (i.e., 512 × 512 pixels on the plane)
cross-sections with 2.5 mm image-slice thickness. The images were taken from the extracranial
skull base to the abdominal region. The geometries in-between slices (slice thickness: 1.25 mm)
were created via an interpolation methodology. Compared with idealized geometries (see
Figure 3(a) and (b)), the subject-specific geometry in Figure 4 maintains more details of local
airways and will have more realistic geometric influence on airflow and aerosol transport.
Figure 3. Configurations of two idealized human upper airway geometries: (a) symmetric idealized geometry from
mouth to G3 with structured hexahedral finite-volume mesh and (b) asymmetric idealized geometry from mouth and
nose to G3 (reprinted from [18]).
Creating high-quality boundary-layer mesh is paramount in computational mesh generation
for the flow domain. It consists of multilayer hybrid tetrahedral/pentahedral elements near the
wall surface to fully contain the viscous sublayers and to resolve any geometric features present
there (see Figures 3 and 4 as examples). Such high local mesh resolution can also help to
accurately calculate values of near-wall derivatives, such as the deposition fluxes. Grid
independence can be checked via indicators such as flow field solution and vapor deposition
fraction (DF).
Realistic 3D imaging of the entire human respiratory system that is 100% accurate is currently
unavailable because: (1) the lung consists of 223 airways plus millions of alveoli, while the
resolution of CT/MRI is insufficient to capture geometries in small scales, i.e., airways exceed-
ing G9; (2) in-vivo measurements are difficult because the whole respiratory system geometry
is time-dependent according to the respiratory movements.
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Figure 4. Configuration of a subject-specific human upper airway geometry from mouth to G9 with tetrahedral mesh
including near-wall prism layers: (a) a subject-specific human upper airway model; (b) mesh details near the glottis; (c)
mesh details at an outlet; (d) sagittal contour with regional names.
2.2. Governing equations
To provide a numerical description of airflow and aerosol behaviors, the governing equation
system for CFPD modeling must be formulated. It contains physical and chemical conservation
laws as well as supplementary equations (see Figure 1). The nonlinear differential governing
equations subject to appropriate initial conditions and boundary conditions (BCs) will be
discretized into algebraic equations and solved using different numerical techniques, e.g.,
finite difference or finite volume method. To promote the understanding of the physical and
chemical characteristics of airflow and aerosol motions in lung, this section introduces the
procedure to formulate equation systems for CFPD models for both conventional and uncon-
ventional aerosol transport and deposition.
2.2.1. Airflow field equations
The airflow dynamics in the respiratory tract is intrinsically unsteady, driven by the pressure
differences under the action of cyclic breathing process. The incompressible Navier-Stokes (N-
S) equation is employed to characterize airflow in the human respiratory tract, accompanied
by continuity equation, energy equation, and constitutive equations [27], which can be written
in tensor form as follows:
Continuity equation
0j
j
u
x
¶ =¶ (1)
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in which uj represents the fluid velocity and ρ is the air density.
Navier-Stokes (N-S) equation
( )i j iji
i
j i j
u uu p Bt x x x
tr r ¶ ¶¶ ¶+ = - + +¶ ¶ ¶ ¶ (2)
where p is the pressure, Bi is the body force including gravity, electromagnetic force, etc. The
viscous stress tensor τij in Eq. (2) is given by:
ji
ij
j i
uu
x xt m
æ ö¶¶= +ç ÷ç ÷¶ ¶è ø
(3)
In Eq. (3), μ is the air viscosity.
Energy equation
( ) ( )¶ é ù¶ ¶ ¶+ = + F +ê ú¶ ¶ ¶ ¶ê úë û
p p j
T
j j j
c T c T Tk St x x x
mr r (4)
where k is thermal conductivity and cp is specific heat capacity. Furthermore, ST is the thermal
sink or source term due to radiation, chemical reaction, phase change, etc. Φ is the dissipation
function which can be given as:
i
ij
j
u
xt
¶F = ¶ (5)
The equation of state as stated by the ideal gas law should complement the above equations
for model closure, i.e., pVm = RT, where Vm is the molar volume and R is the ideal gas con-
stant.
At typical breathing rates, airflow through the oral airway region and first few generations is
incipient turbulent. It becomes laminar at G6-8 and remains so thereafter. In order to capture
the airflow structures in the laminar-to-turbulent flow regimes in human upper airways under
common inhalation flow rates, the low-Reynolds-number (LRN) k-ω model and shear stress
transport (SST) transition model are selected and adapted [27–32], based on their overall
performance in predicting the onset of “laminar-to-turbulent” transition, their computational
efficiency and reasonable accuracy as compared with large eddy simulations (LESs) [30]. For
these Reynolds averaged Navier-Stokes (RANS) models, only averaged values of velocity,
pressure, and other turbulence variables are calculated. The instantaneous fluctuation
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components can be recovered, being approximated by the eddy-interaction model (EIM) [33,
34].
2.2.2. Particle dynamics equations (Lagrangian phase)
For any given inlet concentration of effectively spherical particles (i.e., conventional aerosol
particles), a Lagrangian frame of reference for the trajectory-computations can be employed.
In light of the large particle-to-air density ratio and negligible thermophoretic forces, the
generalized particle trajectory equation for particle i can be described as [35]:
interaction( ) == + + + +r r r r rr p D L BM Gp i i i i i id m u F F F F Fdt (6)
Here, � �� and mp are the velocity and mass of the particle, respectively; � �� represents the drag
force which can be given by:
1 ( - ) | - |2
D p p
i D p i i i iF C A u u u ur=
r r r r r (7)
in which Ap is the projected particle area and CD is the particle drag coefficient [3, 4, 10].
In Eq. (6), � �� is the gravity [35], � ��� is the Brownian motion-induced force [3, 10, 36],� �� is the Saffman lift force [37], and � �interaction is the force due to particle-particle inter-
actions. The interactions may consist of van der Waals interaction and electrostatic interac-
tion. The effect of the lubrication force, or near-wall drag modifications, may also need to
be considered. All forces in Eq. (6) are point forces acting at the center of the particle,
which employ specific empirical correlations corresponding to different particle aerody-
namic properties.
2.2.3. Advection-diffusion equation for vapor (Eulerian phase)
For vapors and nanoparticles less than 50 nm in diameter, their inertial effects can be neglected.
Thus, advection-diffusion equation can be used to describe vapor mass transfer which can be
written as:
( ) ( )j a turbulence Y
j j j
Y Yu Y D D St x x x
é ù¶ ¶ ¶ ¶+ = + +ê ú¶ ¶ ¶ ¶ê úë û
% % (8)
where Y is the vapor mass fraction, �� is the vapor molecular diffusivity in air, ����������� is
the turbulence diffusivity which in laminar flow is zero, and SY is the source term.
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2.2.4. Supplementary equations for modeling unconventional aerosol particles
The governing equations for conventional lung aerosol dynamics discussed above are for
spherical particles with constant diameters. They are not sufficiently accurate to predict the
transport and deposition of unconventional aerosol particles, i.e., nonspherical fiber and
hygroscopic multicomponent droplets interacting with ambient vapors. Therefore, supple-
mentary equations need to be introduced to encompass more physical and chemical mecha-
nisms based on first principles [2–4, 10, 38].
2.2.4.1. Translational and rotational motion equations for ellipsoidal fiber
Based on the point-mass and point-force assumptions adapted by the conventional CFPD
models, particles are in isotropic shape and their rotational motions are neglected. However,
for nonspherical fibers with anisotropic shapes, the orientation determined by their rotational
motions greatly influences the magnitudes and directions of the forces they experience in
translational motion (see Eq. (6)). These forces will differ from those exerted on spherical
particles with the same aerodynamic diameters. In order to capture this effect and provide
accurate prediction of ellipsoidal fiber trajectory (see Figure 5(a) and (b)) based on realistic
physical and chemical mechanisms, the conventional CFPD model was modified as follows
[10, 13, 27]:
a. The translational equation (see Eq. (6)) was revised with force correlations specifically for
ellipsoidal fibers;
b. Euler’s rotation equations were introduced with the Euler quaternions to calculate fiber
rotational motion and orientation at each time step;
c. The hydrodynamic torques acting on fibers are employed with correlations pertinent to
ellipsoids.
Figure 5. Sketches for ellipsoidal fiber modeling: (a) sketch of geometric parameters: semi-minor axis ap, semi-major
axis bp, and aspect ratio β; (b) sketch of coordinate systems: space-fixed frame xyz, body-fixed frame x′y′z′, and co-mov-
ing frame x″y″z″.
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The force and torque correlations for ellipsoidal fibers are documented in [10, 13]. Euler’s
rotation equations for ellipsoidal fiber orientation calculation in the body-fixed x′y′z′-frame
(see Figure 5(b)) are given by:
( )'' ' ' ' ' 'xx y z y z xdI I I Tdtw w w- - = (9a)
( )'' ' ' ' ' 'yy z x z x ydI I I Tdt
w w w- - = (9b)
( )'' ' ' ' ' 'zz z y x y zdI I I Tdtw w w- - = (9c)
Here, (Ix ′, Iy ′, Iz ′) are the particle moments of inertia about the principal axes x′, y′, z′;
(ωx ′, ωy ′, ωz ′) are the particle angular velocities with respect to the principal axes x′, y′, z′; and
(Tx ′, Ty ′, Tz ′) are the torques acting on the particle with respect to the principal axes x′, y′, z′. For
ellipsoidal particles, (Ix ′, Iy ′, Iz ′) can be written as:
( )2 2
' '
1
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'
2
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where ap, bp, and β are semi-minor axis, semi-major axis, and aspect ratio of the ellipsoidal fiber,
respectively (see Figure 5(a)). Details of this advanced CFPD model, i.e., Euler-Lagrange
method enhanced by Euler’s rotation equation (EL-ER), are discussed by Feng and Kleinstre-
uer [10]. With different correlations of forces and torques acting on particles with specific
anisotropic shapes, EL-ER method can be extended to simulate the transport and deposition
of other nonspherical aerosol particles.
2.2.4.2. Governing equations for transport and phase change of droplet-vapor mixture
For liquid aerosols (i.e., droplet-vapor mixture), the phase change between droplet and vapor
(see Figure 6) significantly affects their dispersion and deposition because the induced inertia
changes during their transport. Therefore, the multicomponent mixture plus discrete-droplet
(MCM-DD) model has been developed to simultaneously simulate multicomponent droplet-
vapor interactions with evaporation and condensation effects during their transport in human
respiratory systems [2, 3].
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Figure 6. Schematic of droplet-vapor interactions and phase change dynamics.
2.2.4.3. Governing equations for continuous phase (air-vapor mixture)
Air-vapor mixture is described as a single continuous phase. Therefore, the conservation laws
for mass, momentum, and energy are used to describe the air-vapor mixture transport
phenomena and the advection-diffusion equation for vapor species transport (see Eqs. (1)–(5)
and Eq. (8)). Droplet-vapor interaction will be realized by: (a) introducing source terms into
the energy equation and vapor species transport equation (see Eqs. (4) and (8)) and (b)
employing the local vapor mass fraction in the droplet mass conservation equation (see Eq.
(15)). Specifically, the energy equation of air-vapor mixture can be stated as:
( ) ( ),,
,
( )
,
1
/+D-
=
æ ö= Dç ÷ç ÷è øåò
d celli start f
i start
Nt tY
v d s s d d cell ft ii
S j A dt V t (11)
where subscript a−v means “air-vapor” and N represents the number of volatile components
in droplets. The energy source term �� − ��  is due to the latent heat of evaporation or conden-
sation which is released or absorbed by the droplets per local mesh cell:
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where Nd,cell is the total droplet number in a specified mesh cell, subscript v−d means “between
vapor and droplet”, �� is the average evaporation/condensation mass flux normal to the droplet
surface, and Ls is the latent heat of liquid-vapor phase transition of the sth species.
Furthermore, the advection-diffusion equation of the sth vapor species can be given as:
( ), , ( ), , ,( )a v v s v s Ya v j v s a v a v s v d s
j j j
Y Yu Y D St x x x
r r r- - - - -
é ù¶ ¶¶ ¶+ = +ê ú¶ ¶ ¶ ¶ê úë û
% (13)
Here, the local vaporized/condensed vapor mass flow rate of the aerosol components is added
to its advection-diffusion equation as a source term �� − �, ��  (kg m−3 s−1) which is given by:
( ) ( ) ( )
1
Np p j Ea v a v a v
a v s a v v
s
a v
j
d
sj j j j
c T c u T Tk h St x x
YDx xx
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in which Ad is the droplet surface area. Additionally, dtd represents the droplet phase time
differential and Δtf is the flow time-step length. It is worth mentioning that Eq. (14) describes
the major physics of liquid-vapor mass change.
2.2.4.4. Governing equations for multicomponent droplets
The Lagrangian approach is chosen to track multicomponent droplets, neglecting rotational
motion. The governing equations for discrete droplets are the translational equation (see Eq.
(6)) as well as the mass and energy conservations of droplets and the supplementary equations.
The mass conservation of droplets can be expressed as:
1 1
( )
m m
d
s s dsurfs s
dm j dA j Adt = == - » - ×å åò
(15)
where the average evaporation/condensation mass flux �� is given by [39]:
( ) ( ) ( ), , ,/ ln 1 / 1s a v m a v s d s cell s vsurfj C Sh D d Y Yr - - é ù= × - -ë û% (16)
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in which Ys,vsurf and Ys,cell are the mass fractions of the sth vapor phase at the droplet surface and
the cell center that the droplet is currently in. Eq. (16) assumes that the droplet radius is much
smaller than the distance between the droplet mass center and the mesh cell center. Specifically,
Ys,cell is determined by Eq. (13), which realizes the droplet-vapor interaction modeling.
The energy conservation of droplets is given by:
( ) ( ), ,
1
/
N
a v
d p d d T a v cell d d s s d
sd
k Num c dT dt C T T A L j Ad
-
-
=
æ ö× æ ö= - -ç ÷ ç ÷è øè ø å (17)
where Nu is the Nusselt number.
2.2.5. Lung deposited dose calculation for pharmacokinetic studies
Different mechanisms can induce aerosol deposition in pulmonary route, i.e., diffusion,
sedimentation, inertial impaction, interception, etc. Local deposition of particles in human
airways can be quantified in terms of the deposition fraction (DF) or deposition efficiency (DE)
in a specific region (e.g., oral airway, first, second, and third bifurcations). The DF is calculat-
ed as:
mass of aerosols deposited at region i
total mass of aerosols inhalediDF = (18)
The DE can be calculated as:
mass of aerosols deposited at region 
mass of aerosols entering region i
iDE i= (19)
In addition to the above two traditional deposition parameters DE and DF, a deposition
enhancement factor (DEF) can quantify local particle deposition patterns, which is defined
as:
( )
1 1
/ / /
n n
i i i i
i i
DEF DF A DF A
= =
æ ö= ç ÷è øå å (20)
where Ai is the area of a local wall cell i, n is the number of wall cells in one specific airway
region, and DFi is the local deposition fraction in wall cell i. Clearly, high DEF-values suggest
the presence of “hot spots” of local particle depositions as compared to the regional average.
See Refs. [3, 10] on how to calculate depositions for nonspherical particles, droplets, and
vapors.
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3. Case studies
Employing the advanced CFPD models for unconventional aerosol particle dynamics dis-
cussed in Section 2.4, two case studies are briefly shown in this section: (a) the transport and
deposition of ellipsoidal fiber as a new pulmonary drug carrier in a subject-specific human
upper airway model and (b) the transport, hygroscopic behavior, and deposition of multi-
component electronic cigarette (EC) droplets in an idealized triple bifurcation unit (TBU).
3.1. Transport and deposition of ellipsoidal fibers in a human upper airway
Due to the toxicity of airborne ellipsoidal fibers to human and hence the lack of experimental
data using human volunteers because of the severe ethical constraints, it is essential to
numerically investigate the transport and deposition of fibers in human respiratory systems.
On the other hand, multifunctional micron fibers are also being used as pulmonary drug
carriers for disease treatment. Therefore, the numerical investigations will provide data for
estimations of dosimetry, safety, and the efficacy of drugs in the lungs which are also critical
factors in the development of inhaled medicines.
Figure 7. Ellipsoidal fiber translational and rotational motion in Poiseuille flow (Reave = 173) (reprinted from [10]): (a)
ellipsoidal fiber long-axis directions released at an off-center position y* = −5/6, z* = 0; (b) ellipsoidal fiber long-axis
directions released at center y* = 0, z* = 0; (c) y-direction velocities of fibers with the same volume and different aspect
ratios; (d) trajectories for fibers with the same volume and different aspect ratios.
Considering the significant impact the anisotropic shape has on the accuracy of trajectory
prediction, the one-way coupled EL-ER method discussed in Section 2.2.4.1 was employed [10]
to calculate the translational and rotational motion of submicron ellipsoidal fibers of different
aspect ratios (1 < β < 20). Brownian motion was also considered in both Poiseuille flow (see
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Figure 7(a)–(d)) and complex flows inside a subject-specific human upper airway (see
Figure 8).
To gain basic insight for ellipsoidal particle dynamics, Poiseuille flow with an averaged
Reynolds number of Reave = 173 is considered where ellipsoidal fibers with randomly initialized
incidence angles were released at different inlet-plane positions, their trajectories computed
and visualized (see Figure 7(a)–(d)). Figure 7(a) and (b) show the rotational/translational
motion of the ellipsoidal fibers (β = 14 and ap = 0.5 μm) released at two locations, i.e., off-center
and center. Released at an off-center position (see Figure 7(a)), the coupling of rotation and
translation of the ellipsoidal particle can be clearly observed with periodical sudden turns of
180° in a “clockwise” manner. Released at the center (see Figure 7(b)), the flow velocity
gradients were zero, i.e., no torques were affecting the particle. As a result, the particle kept
its initial orientation till it reached a location where the velocity gradients and resulting torques
were sufficiently large to rotate the particle. The frequency of the sudden rotation is influenced
by the stability of the fibers at different locations of the flow field. It must be noted that using
conventional CFPD models for spherical particles, the rotational motion is neglected and not
able to be visualized.
Figure 8. Total deposition efficiencies of ellipsoidal fibers, including spheres (β = 1.0, at two inhalation flow rates (Qin =
15 L/min and 60 L/min) in a subject-specific human upper airway model as a function of aspect ratio.
Parametric sensitivity analyses were also performed for the aspect ratio effect on the transla-
tional and rotational motion for ellipsoidal fibers with the same equivalent volume diameter
(see Figure 7(c) and (d)). Specifically, Figure 7(c) shows different y-direction velocities of fibers
with the same volume but different aspect ratios. With the increase in aspect ratio β, the y-
direction sedimentation velocity decreases and the rotation frequency of the fibers decreases.
Indeed, with different aspect ratios, the Stokes resistance correction factors in the three
principal directions of the ellipsoidal particle are all changing, which leads to the variation of
the sedimentation velocity in y-direction. Figure 7(d) provides different trajectories of particles
with the same volume and different aspect ratios. Particles with larger β-values have a stronger
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tendency to follow the mainstream and hence travel farther than a particle with a smaller β.
Therefore, it can be conjectured that fibers are more likely to migrate deeper into the lung
airways when compared to spherical particles of the same volume. In other words, when quasi-
aligned to the flow, a fiber experiences a larger drag force in the gravitational direction (i.e.,
y-direction), so that particles with larger aspect ratios may not deposit in parallel flow.
To further investigate the transport characteristics of ellipsoidal fibers with different aspect
ratios and the same volume, parametric studies on fiber transport in a subject-specific human
upper airway with 20-mm inlet are performed. Specifically, a comparison of total deposition
efficiencies of spheres and ellipsoidal fibers for two inhalation flow rates is shown in Figure 8.
The total deposition data indicate that slender toxic ellipsoidal fibers (i.e., those with higher
aspect ratios) are potentially more harmful than thicker ones due to their ability to penetrate
into deeper lung regions when somewhat aligned with the mainstream flow. In contrast, to
treat deeper lung diseases using pulmonary drugs, slender ellipsoidal fibers as drug carriers
may enhance the drug delivery efficacy compared to conventional spherical ones.
3.2. Size change dynamics of multicomponent droplets in a G3-G6 TBU
As tobacco-smoking is addictive with potentially detrimental effects and hence related to high
health-care cost, alternatives such as electronic cigarettes (ECs) have been developed. EC
aerosols consist of multicomponent droplets and vapors, e.g., water, nicotine, glycerol, and
PG. Although ECs can look like and ultimately should “taste” like conventional cigarettes,
their design and function as well as product quality are very different. Debates are still going
on for the use of ECs, with reported positive and negative aspects of EC consumptions [4].
Therefore, investigations on the differences between conventional cigarette smoke and EC
aerosols are of great interest for EC product design as well as government regulations.
In this study, as the first step, the focus is on hygroscopic growth of nanosize multicomponent
droplets and droplet-vapor interactions during transport with subsequent deposition in a
triple bifurcating unit (TBU) representing G3–G6 lung airway (see Figure 9). Using the MCM-
DD model derived in Section 2.2.4.2, electronic cigarette (EC) droplets with different
compositions were compared with conventional smoke particles (CSPs) as well as solid
particles on their different behaviors of evaporation/condensation dynamics during their
transport and deposition in the TBU, with body temperature T = 310.15 K and relative
humidity RH = 99.5% [2].
Figure 10(a) shows the comparisons of hygroscopic behavior between three EC droplets with
different compositions and two conventional cigarette smoke particles (CSPs) with different
compositions (see Table 1 for compositions). At RH = 99.5%, both EC-droplets and CSPs grow
due to condensation effect. However, CSPs #1 and #2 grow less than EC-droplets #B1 to #B3.
This suggests that with initial droplet diameter and ambient environment (humidity) being
the same, EC-droplets #B1 to #B3 will be always larger in size than the liquid CSPs #1 and #2.
Further, these EC-droplets with larger diameters with have higher inertia, and thus being less
affected by the local airflow structure than CSPs.
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Figure 9. G3–G6 triple bifurcation unit (TBU) with hexahedral mesh and airflow velocity contour for Rein = 61.
Figure 10. (a) Droplet diameter growth ratio comparisons between CSPs and EC-droplets; (b) total deposition efficien-
cy of EC-droplet #B2, CSPs #1 and solid particles with different initial diameters (reprinted from [2]).
Water Glycerol PG Nicotine
EC Droplet #B1 0.25 0.398 0.332 0.02
EC Droplet #B2 0.15 0.498 0.332 0.02
EC Droplet #B3 0.05 0.598 0.332 0.02
Table 1. Composition of different EC droplets (mass fraction) used for modeling.
Figure 10(b) shows the total deposition of EC-droplets #B2, CSPs and solid particles in the G3-
G6 TBU, assuming the same initial particle diameters (i.e., 264 nm ≤ dd,ini ≤ 3200 nm). It can be
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observed that with the same initial diameter, the total deposition fraction for the three particles
is EC-droplets #B2 < CSPs #1 < solid particles. Clearly, the hygroscopic growth of droplets and
CSPs limited their Brownian diffusion, thereby reducing TDE in G3–G6. Since this effect is
more prominent for EC-droplets than for CSPs (see Figure 10), the latter therefore has higher
total deposition efficiency values. In other words, CSPs #1 deposit more in the G3–G6 TBU
than #B2 EC-droplets due to lower hygroscopic growth and stronger Brownian diffusion effect.
It can thus be conjectured that EC-droplets may deposit more than CSPs #1 up to the first
bifurcation, due to more pronounced inertial impaction. In contrast, those EC-droplets tend to
deposit more after the first bifurcation in G3–G6 TBUs and deeper lung regions where
Brownian diffusion dominates deposition. Results also indicate the important effect of
hygroscopic behaviors of droplets on the accuracy of deposited-dose predictions.
4. Challenges and future directions
Challenges faced by the current CFPD models and numerical studies for unconventional lung
aerosol dynamics are mostly induced by the point-mass and point-force assumptions, the
resolution of medical imaging techniques, the computational hardware capabilities, as well as
the gap between CFPD prediction capabilities and the needs of toxicologists and health-care
providers. Specifically,
1. The point-mass and point-force assumptions raise the difficulty to apply CFPD modeling
techniques on aerosol transport and deposition simulation in the alveolar region, where
the particle size will not be much smaller than a single mesh element and the assumptions
are not valid.
2. The current resolution of medical imaging techniques is not sufficiently high to identify
small lung airways beyond G8. Therefore, most CFPD models are still for human upper
airways, and it is impossible to reconstruct a complete subject-specific human respiratory
system using CT/MRI imaging data. This restricts CFPD models from simulating aerosol
transport in a full inspiratory-expiratory breathing cycle, i.e., the quantitative prediction
of exhalation clearance of aerosols.
3. Due to the computational resources limitation, most CFPD models still use simplified
mechanisms to reach good compromises between accuracy and computational efficiency,
e.g., one-way coupling for dilute particle suspensions. Therefore, CFPD models are not
suitable for dense particle suspensions in which the particle-particle interactions are not
negligible.
4. Although CFPD models are able to provide high-resolution lung deposition patterns for
unconventional aerosols, the deposited dose cannot be used directly for health risk
assessment or drug delivery efficacy evaluation. Improvements need to be made for the
current CFPD models to calculate the tissue and delivered doses.
This section shows the roadmap to bridge the current simulation techniques to emerging
toxicological/pharmaceutical paradigms to overcome the limitations of current numerical
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simulations. The long-term goal is to build an accurate and cost-effective digital respiratory
simulation framework of subject-specific exposure to inhalable aerosols under realistic
breathing cycles. A proposed framework and kinetic process of this multiscale model, i.e., a
hybrid CFPD-LBM-PBPK model (see Sections 4.1–4.3), is shown in Figure 11. Details of future
researches for extensions and improvements of the current CFPD model and the development
of the next-generation model are discussed below.
Figure 11. Schematic diagrams of the proposed multiscale CFPD-LBM-PBPK model: model framework with a com-
plete human respiratory system geometry and kinetic processes after aerosol inhalation.
4.1. Reconstructing and modeling the entire conducting zone of human lung
In order to provide full-scale regional lung deposited doses in the oral/nasal cavity, conducting
and respiratory zone, it is necessary to find methodologies to represent or reconstruct the
complete human respiratory system geometry, including the smaller airways, which are not
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visible via CT/MRI imaging. Accordingly, two methods can be further developed: (1) coupling
methods with single-path or multiple-path lung airway trees and (2) virtual lung model with
idealized airways for higher generations covering the entire lung conducting zone (G0–G17).
This is crucial to create a full-scale lung aerosol dynamics simulation featuring full breathing
cycles.
4.1.1. Coupling methods with single-path or multiple-path lung airway trees
Coupling methods combine coupled boundary conditions with truncated lung airway trees to
represent the whole conducting zone. Realization of coupling methods can be performed in
the following steps:
1. Divide the whole lung airway trees into segments [40] or truncate the airway tree with
single path or multiple paths left [41–43];
2. Simulate each segment in series or in parallel;
3. The boundary conditions applied to each truncated airway ends will be obtained from the
previous simulation of the next larger section (inhalation) or the next smaller section
(exhalation).
Kleinstreuer and Zhang [40] used the TBU of Weibel type A and constructed the symmetric
and in-plane tracheobronchial airways from G0 to G15, and used coupling method to simulate
airflow and particle deposition in the lung airways with steady-state inhalation flow rate Qin
= 30 L/min. Walters and Luke [42] created an 8-generation airway tree with random connection
angles following Weibel’s lung morphology. They applied coupled pressure boundary
conditions for inhalation cases, and validated the coupling method for inhalation cases. They
extended the application of this coupling method on particle transport in lung airways [43].
Tian et al. [41] developed the stochastic individual path (SIP) and multiple stochastic individ-
ual path (MSIP) approaches to represent the whole-lung geometry. Compared to the coupling
method applied on detached airway geometries [41], this model is able to simulate transient
breathing scenarios. Recently, similar models have also been developed [44, 45].
Since modeling the whole lung is computationally expensive, using the coupling method is
potentially advantageous for fast-solution purposes. However, accuracy of the coupling
methods still needs to be tested compared with using virtual lung model containing the entire
conducting zone without any truncations.
4.1.2. Virtual lung model for the entire conducting zone
To encompass the entire conducting zone, the main objective of virtual lung model recon-
struction is to develop a stochastic algorithm that generates 3D asymmetric human lower lung
airways, which can then be connected to the subject-specific upper lung airways [46–48]. To
establish such a virtual lung model, the upper airway (i.e., mouth and nasal airways, throat,
and trachea) will be exactly reconstructed using image processing software that converts CT/
MRI images. Conducting airways, from the trachea down to the level of the terminal bron-
chioles, will be generated via a stochastic algorithm [46–48]. Specifically, by generating
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geometric variables (i.e., airway diameters, branching angles, and rotation angles of successive
branching planes) stochastically with morphometric restrictions [46], following fractal model
(i.e., Hess-Murray law), or grow from 1-D centerline airway tree [48], a complete tracheobron-
chial airway tree starting from the trachea can be constructed. The accuracy of the geometry
can be judged in two ways: (1) the airways follow the centerlines of a 1D lung airway tree and
(2) it conforms to surface data of the airways segmented from medical imaging. The combined
geometry can be exported as a stereolithography (STL) file that can be used for mesh generation
as needed for computer modeling and simulations.
Compared with coupling methods, constructing a virtual lung model will enable CFPD
simulations with more realistic boundary conditions. It will be computationally achievable to
simulate the multiphase inhaled aerosols in the entire lung conducting zone, with foreseeable
increase in computational power.
4.2. Lattice Boltzmann method (LBM) for aerosol transport in alveoli
A portion of the inhaled aerosol will enter the respiratory zone (G17–G23) of human lung,
which is mainly the alveolar region. In this case, the difficulty in using CFPD model is that the
point-mass and point-force assumptions do not hold and particle-particle interactions are not
negligible. Lattice Boltzmann method (LBM) can be employed for the two-way fluid-particle
interaction and many-particle interaction in alveoli, due to its advantage in resolving particles
that are comparative or larger than the mesh cells in size.
4.2.1. Background and literature review
Lattice Boltzmann method (LBM) solves the Lattice Boltzmann equation (LBE) to obtain the
probability density distribution, which is then used to obtain the pressure and velocity field
through integration. Details of the LBE, discrete speeds, discretization, and boundary condi-
tions are given in [49] and avoided here for brevity. LBM consists of two main steps: (1)
propagation: particle distribution moves along the lattice bonds to neighboring lattice nodes
and (2) collision: particles on the same node interact and adjust velocities to conserve momen-
tum and mass. Communication between nodes in the lattice is required only in the propagation
step requiring message passing or update of the shared memory location.
LBM has been applied to the airflow and particle transport simulations in the human airways
due to the advantages mentioned above compared with CFPD models. Many studies focused
on the flow structures in nasal cavities. For example, Finck et al. [50] first employed LBM for
steady simulations of laminar nasal flow. The model predictions agree well with those of finite-
volume based model using structured grids. However, the LBM has high flexibility in fast grid
generation and easy boundary-condition implementation for such complex geometries
compared to conventional Navier-Stokes solvers. Hörschler et al. [51] compared steady and
unsteady flows in real nasal cavity, and concluded that the transient effects are only important
at Re < 1500. Henn et al. [52] coupled Lagrangian particle tracking method to LBM to simulate
aerosol dynamics in a human nasal cavity. They concluded that transient simulations are
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necessary to study particle dynamics in nasal cavities. Other studies modeled airflow in the
nasal cavities with diagnosed pathologies [53].
There are also existing researches focusing on air flow simulation in human upper airway using
LBM. Ball et al. [54] showed that LBM yields higher fidelity than the RANS models for laminar-
to-turbulent transition flow regime predictions inside an idealized human extrathoracic
airway, as compared to experimental results. Schroeder et al. [55] presented LB simulation
results of pulsatile flow at two breathing frequencies in a human respiratory system down to
G6. They showed that inspiratory flow is characterized by flow separation and secondary flow,
while expiratory flow is characterized by more homogeneous structure but higher vorticity.
This is in contrast with the study by Eite et al. [56], which showed that less vorticity is generated
at exhalation than at inhalation in a nasal cavity. Krause [53] investigated respirations in the
upper part of the human lungs using LBM coupled with a model for the rest of lung, thereby
constructing a two-scale whole lung model. This latter model assumed that the lower part of
the bronchial tree can be described by a symmetrical dyadic tree of pipes, where Poiseuille
type flow holds. Imai et al. [57] developed a LBM with GPU acceleration using an adaptive
meshing method. The model was used to study the effect of breath holding on the deposition
of microparticles in pulmonary airways during inhalation. The subject-specific airway model
contains thirteen generations of airways. The study found that breath holding can effectively
increase particle deposition; yet the effect varies for different particle sizes. Wang and Elgho-
bashi [58] analyzed flow structures in human upper airways including the nasal cavity, the
pharynx, the larynx, and the upper part of the trachea for both healthy and diseased subjects.
The laminar-transitional-turbulent flow in the airway was captured in inspiration, and laminar
flow was found during expiration. The authors proposed that the maximum positive value of
the local time-averaged second derivative of pressure can be used to locate the obstructions
due to disease in the upper airway. It should be noted that most studies claimed that LBM
provides better accuracy for air flow simulation in respiratory systems. However, Chen and
Gutmark [59] did a comparison study of airflow in an idealized human extrathoracic airway.
They claimed that LES is more accurate in predicting root-mean-square flow field compared
with Reynolds stress model and LBM.
In contrast to many existing LBM simulations on airflow patterns in human respiratory
systems, there are only a few studies using LBM for lung aerosol dynamics. Henn et al. [52]
used LBM coupled with Lagrangian tracking method to study microparticle transport in
human nasal cavities. Trunk et al. [60] developed an Euler-Euler LBM method to investigate
the particle dynamics in an idealized bifurcation geometry representing the split from trachea
to main bronchi. Particle capturing BC and numerical stabilization were discussed for lung
aerosol dynamics simulations. Li and Kleinstreuer [61] analyzed transient airflow in two-
dimensional alveoli and bifurcating alveolar ducts. The results highlighted the importance of
alveolar geometries and shapes, as well as the effect of the moving alveolus walls. Implications
of these effects on particle deposition in the alveolar sac were discussed. However, simulation
of particle suspension has not been performed.
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4.2.2. LBM vs. CFPD models
As compared with the CFPD models, LBM has advantages in the following aspects [54]: the
convection operator is linear in LBM; the conservation laws are exactly preserved in LBM; the
calculations are arithmetic operations in LBM; and the boundary conditions (BCs) like no-slip
or moving boundaries are easy to implement. In addition, the entropic lattice Boltzmann
method is attractive in modeling transitional and fully turbulent flows for high-Re simula-
tions [62]. It should be noted that when the particle size is much larger than the lattice size,
LBM can readily account for the two-way fluid-particle interaction and many body interaction
by accurately calculating the hydrodynamic force and torque exerted on the particle by the
fluids [63–65]. Also, Brownian motion of particles arises spontaneously from stochastic
fluctuations in the fluid stress tensor, avoiding application of a random force on particles.
Therefore, LBM is suitable for the simulation of aerosol dynamics, especially in the alveoli sacs.
Furthermore, LBM can also be used to simulate the mucociliary clearance process when
coupled with immersed boundary method or finite difference method [66, 67].
In conclusion, LBM is a rapidly developing method in lung aerosol dynamics simulation. Many
researches have been done concerning airflow dynamics. On the other hand, LBM simulation
including particle transport and deposition in alveoli is still largely unexplored. Much more
efforts are demanded to couple particle transport with airflow simulation using LBM, with
both sub-grid-size particles, and macro-size particles.
4.3. Physiologically based pharmacokinetic (PBPK) models for aerosol translocation into
systemic regions
4.3.1. Background and literature review
Carried by ultrafine aerosols, toxicants and therapeutic components can easily translocate from
lung deposition sites into the systemic circulation, and accumulate in extrapulmonary organs.
Therefore, after obtaining deposited dose of environmental pollutants or pulmonary drugs in
the human respiratory systems, the judgment of potential adverse effects or curing effective-
ness depends on agents’ toxicokinetic/pharmacokinetic information with more insights into
their in-vivo behavior, and then toxicology, i.e., absorption, distribution, metabolism, and
elimination. In order to provide comprehensive regional data for risk assessment, it is neces-
sary to link a whole-body PBPK model to CFPD models, which extends exposure and depo-
sition modeling to health endpoints. The integration of preclinical data generated by CFPD-
PBPK models is also a key to optimize the drug delivery processes for clinical practice.
Physiologically based pharmacokinetic (PBPK) models are based on differential equations that
are designed to simulate the absorption, distribution, metabolism, and excretion (ADME) in
compartments which are connected biological regions, usually in whole animals or humans
[11, 66]. Realistic descriptions of physiology and relevant pathways of metabolism can be
incorporated into PBPK models. The history and details of PBPK models have been well
discussed in [67, 68].
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Focusing on the development of hybrid CFPD-PBPK models, the respiratory system serves as
one compartment, but has significant influence on the whole body as it is the main barrier
between inhaled aerosols and systemic circulation (see Figure 11). As direct inputs to the PBPK
model, regional airway-tissue doses must be accurately calculated from the lung deposited
doses acquired from the CFPD simulations. Therefore, the aim of incorporating CFPD models
with PBPK models is to develop a new boundary condition for site-specific airway-tissue
dosimetry for PBPK modeling that includes essential mechanisms, such as clearance, tissue
reaction, tissue metabolism, diffusion, and blood perfusion. Assuming a linear first-order
constitutive relationship, the material conservation law for compartment i of the airway tissue
can be expressed as:
1
/ ( ) ( )
=
¶ ¶ = - +åNi ij j ji i i
j
c t k c k c S t (21)
where ci is the amount of pathogen per unit volume accumulating in compartment i, kij is the
transfer rate from compartment j to i, and Sij is a general source term representing exterior
inputs, reactions, clearance, etc. The transfer rate, kij, can be determined from existing experi-
mental data, or in vivo deposition/retention and mass transfer data obtained from laboratory
animals. Other biological material properties and site-specific boundary conditions for the
PBPK model will be obtained from the open literature.
Efforts have been made to link CFPD and PBPK/PBTK models for simulations of inhaled drugs
or toxicants, from deposition to systemic regions of interests [69–75]. For example, Rigg et al.
[69] established a numerical model for particle dissolution, absorption, and clearance (DAC)
in the nasal cavity. Their DAC model can estimate the tissue dose for particles after deposition,
which are the more accurate inputs than deposited dose for PBPK/PBTK calculation. Using
subject-specific respiratory system geometries of different species, Corley et al. [70] compared
the parameter difference between humans and animals and adapted the nasal CFD-PBPK
model [71] to perform interspecies variability analyses and sensitivity analyses for vapor
exposure. Anatomic, physiological, and biochemical parameter values were also listed [70].
Parameters such as airway geometry, inhalation flow rates, vapor concentration, partition
coefficient between air and tissue, tissue thickness, and metabolism rate were identified as the
significant factors that influence local vapor uptakes. Recently, they extended the CFD-PBPK
model to transient simulation for toxic vapors [72]. Furthermore, PBPK models with different
compartmental divisions have been established to estimate pulmonary drug delivery [73, 74].
Parameter values were also provided in the context.
4.3.2. Comparisons among CFPD-PBPK, CFPD, and PBPK models
Compared with PBPK models, CFPD-PBPK models have the advantage in considering the
subject variabilities induced by interindividual morphologies of human respiratory systems,
which can be reflected by the different local deposition patterns provided by CFPD calcula-
tions. Additionally, CFPD-PBPK models extend exposure and deposition modeling of CFPD
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to health endpoints, i.e., delivered dosage estimations at site of interests in the whole human
body.
Although research efforts have been made to develop hybrid CFPD-PBPK models as discussed
in Section 4.3.1, none of the existing models display the realism needed for accurate dosimetry
calculations, because they ignored the influence of essential physical and chemical mechanisms
such as hygroscopic characteristics on the dispersion and deposition of droplets in the
respiratory system, and used incomplete human lung airway geometries.
Therefore, future directions to develop more accurate and computationally efficient CFPD-
PBPK models are to make more realistic compartment divisions, mechanism selections, and
parameter value determinations to reflect the underlying aerosol dynamics in systemic
regions [76]. For example, the compartmental division of cellular-level PBPK model should be
based on specific anatomy and mass transfer characteristics of different lung regions. It is also
important to collaborate closely with experimentalists and clinical doctors to find reliable data
sets reflecting responses and pharmacokinetics for evaluating the performance of the CFPD-
PBPK model [77]. Moreover, the determination of human physiological and biochemical
parameters requires strong collaborations. These parameters include breathing rate, skin
surface area, cardiac output, tissue blood flow rates, tissue volumes, partition coefficients, and
biochemical rate constants [68]. Subject-variability must be considered too, i.e., physiological
and biochemical parameter differences due to the differences in interindividual response to
the biological effects of inhaled aerosols. It will not only contribute to the evaluation of the
confidence in PBPK models on the lack of precise knowledge of the parameter values, but also
contribute to the uncertainty analyses for the extrapolations between animals and humans.
The error source must be identified and reduced to enhance the accuracy of the numerical
results [75].
4.4. Others
Other numerical methods that can be integrated or employed to improve or replace current
CFPD models are direct numerical simulations (DNSs) for turbulence [78], complete numerical
simulations (CNSs) for multiphase flow [79], discrete element methods (DEMs) [80], etc. They
will be able to extend the CFPD model capabilities by encompassing more underlying physics
(e.g., particle-particle interactions) and less simplifications (e.g., point-mass and point-force
assumptions).
4.4.1. Complete numerical simulations (CNSs) for multiphase flow
Complete numerical simulation (CNS) methods are numerical techniques where the Navier-
Stokes equations are applied to finite-size particles instead of introducing point-mass and
point-force assumptions. Particle motion is governed by the Newton’s second law, based on
the hydrodynamic forces calculated from the fluid equations. For CNS-based multiphase flow,
all surface and collision forces due to fluid-particle and particle-particle interactions should be
accurately calculated to obtain the velocity, pressure, and stress fields surrounding each
particle [35]. Specifically, mesh scales for CNS methods are much lower than particle sizes;
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hence, surface forces such as drag force and lift force, as well as interaction force between
particles can be directly integrated from the shear stress and pressure distribution along the
particle surfaces. This avoids empirical correlations, such as drag and lift coefficients.
Compared with CFPD models which are based on Euler-Euler or Euler-Lagrange methods,
CNS is a mesoscale model that can accurately describe motions of particles with arbitrary
shapes. As such, CNS of multiphase flows can promote fundamental understanding of the
underlying physics, e.g., the nonlinear and geometrically complicated phenomena of particle-
particle and particle-wall interactions.
With the enhancement of the computational power in the future, CFPD models will be replaced
by DNS and CNS methods to simulate unconventional lung aerosol dynamics. However, the
computational cost of DNS and CNS methods is still too high for engineering application.
Applying these methods to a large number of particles is not realistic according to the current
computational resources [79].
4.4.2. Discrete element method (DEM)
Discrete element method (DEM) can provide transient forces and torques acting on individual
particles. DEM was first proposed by Cundall and Strack [81] based on molecular dynamics.
The most attractive feature of DEM method is its relatively efficient algorithms for the contact
detection and contact force calculation between arbitrary shaped particles [82]. Soft-sphere
models are the most common type of models used in DEM, which simplify particle-particle
interaction force with spring-dashpot-slider systems [27]. Determinations of the stiffness
coefficients and damping coefficients are essential in DEM interaction models. Contact forces
are calculated in two steps in DEM methods [83]:
1. Contact detection: identify which particles are contacting;
2. Contact resolution: the actual contact forces are calculated. This step involves the accurate
calculation of the contact geometry and kinematics, typically characterized by the overlap
depth/separation and sometimes also relative tangential motion.
Additionally, for nonspherical particles, representation of the particle shape is also essential
in DEM simulations. Two major treatments of the particle shape representation are widely
used for the contact detection and contact force calculation between nonspherical particles [84]:
superquadric method and multisphere method. The algorithm to integrate DEM with Euler-
Euler and Euler-Lagrange models (see Figure 12 for a standard flow chart) for dense particulate
flow is straightforward [38]. However, there are two key challenges:
1. Spring-dashpot-slider systems are not designed for micro-/nano-particles. Coefficients,
i.e., equivalent stiffness and damping coefficient, need to be determined via experiments
specifically for ultrafine particles. Or else, the validity of using soft-sphere models needs
to be tested.
2. DEM is not computationally efficient on handling aerosol transport and deposition in
human respiratory systems, in which the difference in characteristic dimensions between
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particles and flow domains is too large. Therefore, efficient algorithms need to be devel-
oped.
Figure 12. The algorithm of coupling DEM with conventional multiphase flow models.
5. Summary
In this chapter, CFPD models have been systematically overviewed, with emphases on
simulating the transport and deposition of unconventional ultrafine aerosol particles in human
upper airways. Compared to other numerical models for inhaled aerosol dose [1], CFPD
models provide more detailed characterizations of airflow and aerosol deposition patterns
with a reasonable degree of accuracy and computational cost.
However, in order to provide comprehensive tissue and delivered dosage data for risk
assessment or drug delivery efficacy evaluation, it is necessary to improve current CFPD
models and extend lung deposition calculation by integrating with other simulation techni-
ques to build a multiscale dosimetry model (see Figure 11 for the framework). This multidis-
ciplinary effort requires expertise in medical imaging, airway geometric reconstruction,
computational techniques, pulmonary physiology and medicine, fluid mechanics, etc. From a
physics viewpoint, the future numerical models for lung aerosol dynamics will provide
comprehensive analysis of the fate of inhaled particulate matter under realistic conditions,
namely, actual particle characteristics, inhalation flow rates, and human respiratory systems.
The anticipated results will greatly increase understanding of distinct particle transport/
deposition phenomena under realistic inhalation conditions as well as quantify the knowledge
base for dosimetry and health-effect studies in the case of toxic particles, and optimal drug-
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aerosol targeting in the case of therapeutic particles. Relevant numerical researches will lead
to understanding and quantification of dosimetry effects of inhalation hazards, more accurate
evaluation of toxic particle fate in the human lung, and improved estimates of drug delivery
points for treating lung and other diseases.
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